3-(2-cyanopropan-2-yl)-N-(4-methyl-3-(3-methyl-4-oxo-3,4-dihydroquinazolin-6-ylamino)phenyl)benzamide (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View 3-(2-cyanopropan-2-yl)-N-(4-methyl-3-(3-methyl-4-oxo-3,4-dihydroquinazolin-6-ylamino)phenyl)benzamide's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
3-(2-cyanopropan-2-yl)-N-(4-methyl-3-(3-methyl-4-oxo-3,4-dihydroquinazolin-6-ylamino)phenyl)benzamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	DUSP6 Gene (Entity type)	-0.023800777
3-(2-cyanopropan-2-yl)-N-(4-methyl-3-(3-methyl-4-oxo-3,4-dihydroquinazolin-6-ylamino)phenyl)benzamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	MMP9 Gene (Entity type)	-0.007261819
3-(2-cyanopropan-2-yl)-N-(4-methyl-3-(3-methyl-4-oxo-3,4-dihydroquinazolin-6-ylamino)phenyl)benzamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	KRT5 Gene (Entity type)	0.0064291563
3-(2-cyanopropan-2-yl)-N-(4-methyl-3-(3-methyl-4-oxo-3,4-dihydroquinazolin-6-ylamino)phenyl)benzamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	IER3 Gene (Entity type)	-0.007834922
3-(2-cyanopropan-2-yl)-N-(4-methyl-3-(3-methyl-4-oxo-3,4-dihydroquinazolin-6-ylamino)phenyl)benzamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	ABLIM1 Gene (Entity type)	0.0057845693
3-(2-cyanopropan-2-yl)-N-(4-methyl-3-(3-methyl-4-oxo-3,4-dihydroquinazolin-6-ylamino)phenyl)benzamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	CSRP2 Gene (Entity type)	0.0053831595
3-(2-cyanopropan-2-yl)-N-(4-methyl-3-(3-methyl-4-oxo-3,4-dihydroquinazolin-6-ylamino)phenyl)benzamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	TP53I3 Gene (Entity type)	0.0060044993
3-(2-cyanopropan-2-yl)-N-(4-methyl-3-(3-methyl-4-oxo-3,4-dihydroquinazolin-6-ylamino)phenyl)benzamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	SPRY2 Gene (Entity type)	-0.010905079
3-(2-cyanopropan-2-yl)-N-(4-methyl-3-(3-methyl-4-oxo-3,4-dihydroquinazolin-6-ylamino)phenyl)benzamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	EGR3 Gene (Entity type)	-0.009094814
Ulixertinib Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	3-(2-cyanopropan-2-yl)-N-(4-methyl-3-(3-methyl-4-oxo-3,4-dihydroquinazolin-6-ylamino)phenyl)benzamide Compound (Entity type)	0.5911966562271118

3-(2-cyanopropan-2-yl)-N-(4-methyl-3-(3-methyl-4-oxo-3,4-dihydroquinazolin-6-ylamino)phenyl)benzamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
DUSP6
Gene (Entity type)
-0.023800777

3-(2-cyanopropan-2-yl)-N-(4-methyl-3-(3-methyl-4-oxo-3,4-dihydroquinazolin-6-ylamino)phenyl)benzamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
MMP9
Gene (Entity type)
-0.007261819

3-(2-cyanopropan-2-yl)-N-(4-methyl-3-(3-methyl-4-oxo-3,4-dihydroquinazolin-6-ylamino)phenyl)benzamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
KRT5
Gene (Entity type)
0.0064291563

3-(2-cyanopropan-2-yl)-N-(4-methyl-3-(3-methyl-4-oxo-3,4-dihydroquinazolin-6-ylamino)phenyl)benzamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
IER3
Gene (Entity type)
-0.007834922

3-(2-cyanopropan-2-yl)-N-(4-methyl-3-(3-methyl-4-oxo-3,4-dihydroquinazolin-6-ylamino)phenyl)benzamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
ABLIM1
Gene (Entity type)
0.0057845693

3-(2-cyanopropan-2-yl)-N-(4-methyl-3-(3-methyl-4-oxo-3,4-dihydroquinazolin-6-ylamino)phenyl)benzamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
CSRP2
Gene (Entity type)
0.0053831595

3-(2-cyanopropan-2-yl)-N-(4-methyl-3-(3-methyl-4-oxo-3,4-dihydroquinazolin-6-ylamino)phenyl)benzamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
TP53I3
Gene (Entity type)
0.0060044993

3-(2-cyanopropan-2-yl)-N-(4-methyl-3-(3-methyl-4-oxo-3,4-dihydroquinazolin-6-ylamino)phenyl)benzamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
SPRY2
Gene (Entity type)
-0.010905079

3-(2-cyanopropan-2-yl)-N-(4-methyl-3-(3-methyl-4-oxo-3,4-dihydroquinazolin-6-ylamino)phenyl)benzamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
EGR3
Gene (Entity type)
-0.009094814

Ulixertinib
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
3-(2-cyanopropan-2-yl)-N-(4-methyl-3-(3-methyl-4-oxo-3,4-dihydroquinazolin-6-ylamino)phenyl)benzamide
Compound (Entity type)
0.5911966562271118

DISPLAY PER PAGE

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.